International Immunology, Vol. 14, No. 1, 1-11,
January 2002
© 2002 Japanese Society for Immunology
The IL-4 production capability of different strains of naive CD4+ T cells controls the direction of the Th cell response
1 Divisions of Immunobiology and
2 Biotechnology, Research Institute for Biological Sciences, Science University of Tokyo, 2669 Yamazaki, Noda City, Chiba 278-0022, Japan
3 Exploratory Research Group, Sumitomo Pharmaceuticals Research Center, Takarazuka City, Hyougo 665-0051, Japan
4 Department of Applied Biological Science, Science University of Tokyo, Noda City, Chiba 278-8510, Japan
Correspondence to: M. Kubo
The qualitative nature of an immune response raised against infectious pathogens depends upon the phenotypes of Th cell subsets, which secrete distinct types of cytokines. Genetic background is known to greatly influence the nature of the Th cell response. However, the precise nature of this influence still remains unclear. In the present study, we demonstrate that CD62L+, CD44low and CD4+ naive T cells from BALB/c mice are capable of producing significant amounts of IL-4, while naive T cells from B10.D2 mice exhibit no IL-4 production. The addition of exogenous IL-4 into the B10.D2 induction culture recovered Th2 development, thereby indicating that the potential of naive T cells to secrete IL-4 at primary activation is likely to substantially influence development of Th2. Regulation of the IL-4 gene in naive T cells differs from that in cells committed towards becoming Th2 cells, based on the observation that naive T cells from STAT6-deficient mice having a BALB/c background produce detectable amounts of IL-4. The IL-4 promoter region was found to be equally histone acetylated in both BALB/c and B10.D2 naive T cells by primary TCR activation. Interestingly, the expression levels of transcription factors NF-AT and GATA-3, which regulate promoter activity, differ between BALB/c and B10.D2 cells. These results suggest that the differences in expression level between the two transcriptional factors may affect the potential of naive T cells to secrete IL-4, which may subsequently influence the development of Th cell phenotypes.
Keywords: IL-4, naive T cell, NF-AT, strain difference, Th2
Transmitting editor: T. Watanabe
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Maneechotesuwan, Y. Xin, K. Ito, E. Jazrawi, K.-Y. Lee, O. S. Usmani, P. J. Barnes, and I. M. Adcock Regulation of Th2 Cytokine Genes by p38 MAPK-Mediated Phosphorylation of GATA-3 J. Immunol., February 15, 2007; 178(4): 2491 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yagi, Y. Arimura, H. Takatori, H. Nakajima, I. Iwamoto, and T. Uchiyama Genetic background influences Th cell differentiation by controlling the capacity for IL-2-induced IL-4 production by naive CD4+ T cells Int. Immunol., December 1, 2006; 18(12): 1681 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baguet, X. Sun, T. Arroll, A. Krumm, and M. Bix Intergenic Transcription Is Not Required in Th2 Cells to Maintain Histone Acetylation and Transcriptional Permissiveness at the Il4-Il13 Locus J. Immunol., December 15, 2005; 175(12): 8146 - 8153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tsukada, A. Ozaki, T. Hanada, T. Chinen, R. Abe, A. Yoshimura, and M. Kubo The role of suppressor of cytokine signaling 1 as a negative regulator for aberrant expansion of CD8{alpha}+ dendritic cell subset Int. Immunol., September 1, 2005; 17(9): 1167 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baguet, J. Epler, K. W. Wen, and M. Bix A Leishmania major Response Locus Identified by Interval-specific Congenic Mapping of a T Helper Type 2 Cell Bias-controlling Quantitative Trait Locus J. Exp. Med., December 20, 2004; 200(12): 1605 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Setterblad, C. Roucard, C. Bocaccio, J.-P. Abastado, D. Charron, and N. Mooney Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells J. Leukoc. Biol., July 1, 2003; 74(1): 40 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Schjetne, K. M. Thompson, N. Nilsen, T. H. Flo, B. Fleckenstein, J.-G. Iversen, T. Espevik, and B. Bogen Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target J. Immunol., July 1, 2003; 171(1): 32 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsumoto, Y.-i. Seki, R. Watanabe, K. Hayashi, J. A. Johnston, Y. Harada, R. Abe, A. Yoshimura, and M. Kubo A Role of Suppressor of Cytokine Signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated Interleukin 2 Production J. Exp. Med., February 17, 2003; 197(4): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Asai, T. Jinno, and T. Ogawa Oral Treponemes and Their Outer Membrane Extracts Activate Human Gingival Epithelial Cells through Toll-Like Receptor 2 Infect. Immun., February 1, 2003; 71(2): 717 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Barbieri, V. Deffrennes, T. Prod'homme, J. Vedrenne, F. Baton, C. Cortes, A. Fischer, M.-R. Bono, B. Lisowska-Grospierre, D. Charron, et al. Isoforms of the class II transactivator protein Int. Immunol., August 1, 2002; 14(8): 839 - 848. [Abstract] [Full Text] [PDF] |
||||




